Novartis AG (NVS)
NYSE: NVS · Real-Time Price · USD
97.11
+0.34 (0.35%)
Dec 20, 2024, 4:00 PM EST - Market closed
Novartis AG Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Novartis AG stock have an average target of 121.25, with a low estimate of 114 and a high estimate of 130. The average target predicts an increase of 24.86% from the current stock price of 97.11.
Analyst Consensus: Hold
* Price targets were last updated on Oct 30, 2024.
Analyst Ratings
The average analyst rating for Novartis AG stock from 6 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 6 | 5 | 6 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 6 | 5 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Erste Group | Erste Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 19, 2024 |
| BMO Capital | BMO Capital | Hold Maintains $118 → $120 | Hold | Maintains | $118 → $120 | +23.57% | Oct 30, 2024 |
| B of A Securities | B of A Securities | Strong Buy → Hold Downgrades $135 → $130 | Strong Buy → Hold | Downgrades | $135 → $130 | +33.87% | Sep 11, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy → Hold Downgrades $119 → $121 | Strong Buy → Hold | Downgrades | $119 → $121 | +24.60% | Sep 5, 2024 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Sep 3, 2024 |
Financial Forecast
Revenue This Year
51.34B
from 46.66B
Increased by 10.04%
Revenue Next Year
53.68B
from 51.34B
Increased by 4.55%
EPS This Year
7.72
from 7.10
Increased by 8.68%
EPS Next Year
8.33
from 7.72
Increased by 7.90%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 54.4B | 57.7B | 59.5B | |||
| Avg | 51.3B | 53.7B | 54.8B | |||
| Low | 48.3B | 48.9B | 48.8B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 16.6% | 12.4% | 10.9% | |||
| Avg | 10.0% | 4.5% | 2.1% | |||
| Low | 3.6% | -4.8% | -9.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 9.12 | 10.62 | 11.54 | |||
| Avg | 7.72 | 8.33 | 8.89 | |||
| Low | 7.07 | 5.76 | 7.48 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 28.4% | 37.6% | 38.5% | |||
| Avg | 8.7% | 7.9% | 6.8% | |||
| Low | -0.5% | -25.3% | -10.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.